Cargando…
Treatment regimens, patient reported outcomes and health-related quality of life in children with moderate and severe hemophilia A in China: using real-world data
BACKGROUND: Prophylaxis therapy for children with moderate and severe hemophilia A (HA) is the optimal treatment regimen. The real-world treatment regimens, patient-reported outcomes, and health-related quality of life (HRQoL) in children with moderate and severe HA in China are less known. OBJECTIV...
Autores principales: | Zhang, Luying, Zhang, Peng, Chen, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403888/ https://www.ncbi.nlm.nih.gov/pubmed/37542281 http://dx.doi.org/10.1186/s13023-023-02835-x |
Ejemplares similares
-
Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis
por: O’Hara, Jamie, et al.
Publicado: (2021) -
Real-world utilities and health-related quality-of-life data in hemophilia patients in France and the United Kingdom
por: Carroll, Liz, et al.
Publicado: (2019) -
Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
por: Liu, Guoqing, et al.
Publicado: (2022) -
Racial Differences in Chronic Pain and Quality of Life among Adolescents and Young Adults with Moderate or Severe Hemophilia
por: McLaughlin, John M., et al.
Publicado: (2015) -
Iranian Low-dose Escalating Prophylaxis Regimen in Children with Severe
Hemophilia A and B
por: Eshghi, Peyman, et al.
Publicado: (2017)